Delivery Order SPE2DB20D3505-SPE2DB25FYCFA
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The delivery order, valued at $33,789.66, represents a firm fixed price contract with an ultimate completion date of September 19, 2025, and was competitively awarded with no set-aside designation. Performance will occur at the vendor's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 25, 2025, by the Defense Logistics Agency to supply Ozempic 2 mg/dose (8 mg/3 ml) injectable medication. The contract, valued at $14,490.85, represents a firm fixed price delivery order with an ultimate completion date of August 26, 2025. This award was not designated as a set-aside contract and was competitively awarded through open competition. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 27, 2025, valued at $8,937.86 for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials. This competitive, non-set-aside contract is funded through the Defense Logistics Agency's Medical Supply Chain division and is set to be completed by August 28, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,870.86 and is scheduled for completion by July 31, 2025. The award represents a child contract action under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 8, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This firm fixed-price delivery order, valued at $3,138.37, was competitively awarded without set-aside designation and is scheduled for completion by August 11, 2025. The order will be fulfilled from the vendor's location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on May 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication. The contract, valued at $1,566.65 with a firm fixed-price structure, is scheduled for completion by June 2, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials. This competitively awarded, non-set-aside firm fixed-price delivery order has a ceiling value of $2,015.92 and an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 20, 2025, valued at $9,486.77. The contract calls for the delivery of Ozempic 0.25–0.5 mg/dose pens (3 mL) to support federal medical supply requirements. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for ultimate completion by August 21, 2025, with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 21, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $28,322.36 and an ultimate completion date of July 22, 2025. The contract carries no set-aside designation, indicating it was competed among qualified vendors through open...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $54,717.86 by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract is characterized as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and was competitively awarded with no set-aside designation. This award is a child contract issued...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCFADelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract, valued at $11,989.73, carries a firm fixed price and is classified as a non-set-aside, competitively awarded procurement. The delivery order is scheduled for completion by September 8, 2025, with the place of performance located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The DLA Troop Support Medical contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this IDC arrangement, the company fulfills critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The supply of Ozempic, a diabetes medication, aligns with the broader pharmaceutical portfolio delivered under the contract, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains supporting the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 9/5/25 |